Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Eclinicalmedicine
|
February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution
Allison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium
Tanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study
H M Katzenstein, L C Bowman, G M Brodeur, et al.
Cancer
|
February 18, 2017
Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee
Howard M Katzenstein, Wayne L Furman, Marcio H Malogolowkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study
Morris Kletzel, Howard M Katzenstein, Paul R Haut, et al.
Clinical Genitourinary Cancer
|
November 12, 2024
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
Petros Grivas, Pedro Barata, Helen Moon, et al.
Cancer
|
April 4, 2003
Fibrolamellar hepatocellular carcinoma in children and adolescents
Howard M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Journal of Pediatric Surgery
|
May 26, 2019
Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee
Christopher B Weldon, Arin L Madenci, Gregory M Tiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Cancer Letters
|
June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects
Bruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Eclinicalmedicine
|
February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution
Allison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium
Tanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study
H M Katzenstein, L C Bowman, G M Brodeur, et al.
Cancer
|
February 18, 2017
Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee
Howard M Katzenstein, Wayne L Furman, Marcio H Malogolowkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study
Morris Kletzel, Howard M Katzenstein, Paul R Haut, et al.
Clinical Genitourinary Cancer
|
November 12, 2024
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
Petros Grivas, Pedro Barata, Helen Moon, et al.
Cancer
|
April 4, 2003
Fibrolamellar hepatocellular carcinoma in children and adolescents
Howard M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Journal of Pediatric Surgery
|
May 26, 2019
Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee
Christopher B Weldon, Arin L Madenci, Gregory M Tiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Cancer Letters
|
June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects
Bruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Page
of 12